I think the delays are more detailing the logistics , distribution, protocols etc.. I believe the UK is already sold on the drug itself . But if the UK is going to compete with the US , I want to know how many doses you can commit to. How will you get them here and when . I also want to know the guidance for physicians on when and when not to inject a mm patient . It’s NEWS2 but one item in NEWS2 elevated? Three ? Pricing is also part of the package as well as working out distribution internally within the UK Healthcare system...then I have to document all the details around the drug getting an EUA and both parties singing off which is the legal part of all of this